Quantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heart

BMC Cardiovascular Disorders

Research Article

Anita L Quon¹  Joseph R Casey¹  John Mullen²  Bernardo V Alvarez³ 

[1] Department of Biochemistry, and Membrane Protein Disease Research Group, University of Alberta, T6G 2H7, Edmonton, AB, Canada;Department of Surgery, University of Alberta, T6G 2H7, Edmonton, AB, Canada;Universidad Nacional de La Plata, La Plata, Argentina;

关键词: Heart failure;    Carbonic anhydrase;    pH regulation;    Gene expression;    Heart transplant;    Cardiac hypertrophy;   

DOI  :  10.1186/1471-2261-13-2

 received in 2012-09-11, accepted in 2012-12-17,  发布年份 2013

来源: Springer

【 摘 要 】

BackgroundCarbonic anhydrase enzymes (CA) catalyze the reversible hydration of carbon dioxide to bicarbonate in mammalian cells. Trans-membrane transport of CA-produced bicarbonate contributes significantly to cellular pH regulation. A body of evidence implicates pH-regulatory processes in the hypertrophic growth pathway characteristic of hearts as they fail. In particular, Na+/H+ exchange (NHE) activation is pro-hypertrophic and CA activity activates NHE. Recently Cardrase (6-ethoxyzolamide), a CA inhibitor, was found to prevent and revert agonist-stimulated cardiac hypertrophy (CH) in cultured cardiomyocytes. Our goal thus was to determine whether hypertrophied human hearts have altered expression of CA isoforms.MethodsWe measured CA expression in hypertrophied human hearts to begin to examine the role of carbonic anhydrase in progression of human heart failure. Ventricular biopsies were obtained from patients undergoing cardiac surgery (CS, n = 14), or heart transplantation (HT, n = 13). CS patients presented mild/moderate concentric left ventricular hypertrophy and normal right ventricles, with preserved ventricular function; ejection fractions were ~60%. Conversely, HT patients with failing hearts presented CH or ventricular dilation accompanied by ventricular dysfunction and EF values of 20%. Non-hypertrophic, non-dilated ventricular samples served as controls.ResultsExpression of atrial and brain natriuretic peptide (ANP and BNP) were markers of CH. Hypertrophic ventricles presented increased expression of CAII, CAIV, ANP, and BNP, mRNA levels, which increased in failing hearts, measured by quantitative real-time PCR. CAII, CAIV, and ANP protein expression also increased approximately two-fold in hypertrophic/dilated ventricles.ConclusionsThese results, combined with in vitro data that CA inhibition prevents and reverts CH, suggest that increased carbonic anhydrase expression is a prognostic molecular marker of cardiac hypertrophy.

【 授权许可】

Unknown   
© Alvarez et al.; licensee BioMed Central Ltd. 2013. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.